v3.26.3
Notes to the consolidated statements of income - Other operating income and expense (Details) - EUR (€)
€ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Other operating income and expense        
Foreign exchange gains € 72,552 € 36,200 € 279,394 € 301,410
Gains on right-of-use assets, from the sale of fixed assets, clinics and investments 1,961 1,097 15,654 7,668
Revaluation of certain investments 16 (178) 3,273 7,328
Income from strategic transactions and programs 19,871 2,405 34,135 10,342
Changes in fair value of the derivatives embedded in Virtual Power Purchase Agreements (vPPAs) 10,858 2,010 14,969 30,605
Other 11,107 14,543 47,331 39,883
Other operating income 116,365 56,077 394,756 397,236
Foreign exchange losses 79,352 47,958 290,252 338,678
Losses on right-of-use assets, from the sale of fixed assets, clinics and investments 517 5,200 2,900 8,162
Revaluation of certain investments 4,339 5,027 10,719 70,173
Expenses from strategic transactions and programs 119,727 53,225 285,319 94,084
Changes in fair value of the derivatives embedded in vPPAs 8,446 3,797 28,869 14,443
Other 28,429 10,067 75,743 51,304
Other operating expense 240,810 125,274 693,802 576,844
Reclassification adjustments of foreign currency translation amounts previously classified within other comprehensive income, included in expenses from strategic transactions and programs € 0 (45,083) 481 (46,088)
Legacy Portfolio Optimization        
Other operating income and expense        
Reclassification adjustments of foreign currency translation amounts previously classified within other comprehensive income, included in expenses from strategic transactions and programs   € (45,083) € 0 € (45,083)